Skip to content

Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect

Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06295783
Enrollment
300
Registered
2024-03-06
Start date
2024-06-10
Completion date
2027-02-01
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation

Brief summary

To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.

Detailed description

Primary Objectives: • To investigate how different toxicity questionnaires with different scoring systems can be reliably translated to each other by estimating different measures of correlation between items and summary scores across different questionnaires.

Interventions

OTHERMDASI-HN

Given by Questionnaire

Given by Questionnaire

OTHEREORTC HN35

Given by Questionnaire

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * English as a primary language * Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson * Ability to complete the survey(s) of their own volition

Exclusion criteria

* Age \< 18 years * Non-English speaking participants * Participants who are receiving or have received RT in a non-HN site. * Participants in follow up and over 5 years from post-treatment * Neurocognitive deficits that render patients unable to complete the survey(s) on their own.

Design outcomes

Primary

MeasureTime frameDescription
Safety and adverse events (AEs)Through study completion; an average of 1 yearIncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)

Countries

United States

Contacts

Primary ContactAmy Moreno, MD
akmoreno@mdanderson.org(713) 745-4590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026